A

Avenue Therapeutics
D

ATXI

1.35000
USD
-0.05
(-3.57%)
مغلق
حجم التداول
320
الربح لكل سهم
-2
العائد الربحي
-
P/E
0
حجم السوق
2,772,796
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AGIO
    1.430
    (4.23%)
    35.210 USD
    A
    ARWR
    -1.040
    (-4.97%)
    19.900 USD
    G
    GLYC
    -0.00930
    (-3.06%)
    0.29490 USD
    I
    INCY
    0.790
    (1.11%)
    72.150 USD
    K
    KPTI
    -0.00940
    (-1.55%)
    0.59840 USD
    M
    MGNX
    -0.13000
    (-4.50%)
    2.76000 USD
    R
    RARE
    -1.920
    (-4.31%)
    42.590 USD
    S
    SRPT
    -2.010
    (-1.86%)
    106.280 USD
    U
    UTHR
    -6.03
    (-1.64%)
    361.18 USD
    المزيد
الأخبار
المقالات

العنوان: Avenue Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.